U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Description

AC-2592 (glucagon-like peptide 1, or GLP-1) was being in development by Amylin Pharmaceuticals for the treatment of severe congestive heart failure. AC-2592 is a glucagon like peptide 1 receptor agonist.

Originator

Approval Year

Unknown
139594
PubMed

PubMed

TitleDatePubMed
Gateways to clinical trials.
2010 May
Patents

Patents

08524726
5
20050070539
2
6756374
2
9212177
2
WO2011015037A1
2
WO2012044531A1
2
WO2013171334A1
2

Sample Use Guides

In Vivo Use Guide
Congestive Heart Failure: Continuous subcutaneous infusion (via pump), dose based on subject body weight
Route of Administration: Parenteral
Name Type Language
GLUCAGON-LIKE PEPTIDE-I(7-36) AMIDE ACETATE
Common Name English
L-ARGININAMIDE, L-HISTIDYL-L-ALANYL-L-.ALPHA.-GLUTAMYLGLYCYL-L-THREONYL-L-PHENYLALANYL-L-THREONYL-L-SERYL-L-.ALPHA.-ASPARTYL-L-VALYL-L-SERYL-L-SERYL-L-TYROSYL-L-LEUCYL-L-.ALPHA.-GLUTAMYLGLYCYL-L-GLUTAMINYL-L-ALANYL-L-ALANYL-L-LYSYL-L-.ALPHA.-GLUTAMYL-L-P
Systematic Name English
HUMAN GLP-1-(7-36)-AMIDE ACETATE
Common Name English
HUMAN GLUCAGON-LIKE PEPTIDE-1 AMIDE (7-36) ACETATE
Common Name English
GLP-1 (7-36) AMIDE ACETATE
Common Name English
Code System Code Type Description
FDA UNII
096X7FPZ1N
Created by admin on Sat Dec 16 15:04:13 GMT 2023 , Edited by admin on Sat Dec 16 15:04:13 GMT 2023
PRIMARY
CAS
1119517-19-9
Created by admin on Sat Dec 16 15:04:13 GMT 2023 , Edited by admin on Sat Dec 16 15:04:13 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966